# Consensus vs Empedoc AI

Consensus records 6,014,388 monthly visits with -1.2% month-over-month growth and Freemium pricing. Empedoc AI records 0 monthly visits with 0% growth and Contact for Pricing pricing.

| Metric | [Consensus](https://openaitools.app/tool/consensus) | [Empedoc AI](https://openaitools.app/tool/empedoc-ai) |
| :--- | :--- | :--- |
| Website URL | https://consensus.app | https://empedoclabs.com/ |
| Categories | AI Search Engine, AI Research Tool, AI Papers, AI Article Summarizer | AI Predictions, AI Medical Diagnosis, AI Healthcare, AI Symptom Checker |
| Pricing Model | Freemium | Contact for Pricing |
| Monthly Visits | 6,014,388 | 0 |
| MoM Growth Rate | -1.2% | 0% |
| Primary Market | United States | Global |
| Direct Visits | 2,918,713 | 0 |
| Review Score | 4.7 | 4.1 |
| Saved Count | 31 | 0 |
| Supported Platforms | Website | Website |

## Consensus

Consensus works like a scholarly search engine supercharged by AI. Instead of returning a flat list of PDFs, you ask a natural-language research question and Consensus extracts claims from relevant papers, then shows you what the studies actually find. A Consensus Meter summarizes the weight of evidence for yes/no questions, so you can see at a glance whether scientists largely agree, disagree, or remain divided.

The platform indexes hundreds of millions of peer-reviewed papers spanning medicine, biology, psychology, economics and more. Answers link straight back to the source studies, and you can filter by study design, journal quality, sample size and publication year to separate stronger evidence from weaker signals. Features like Deep Search, Topic Synthesis and Skills let researchers build a working knowledge base over time rather than starting from scratch on every query.

Consensus is designed for researchers, clinicians, students and analysts who need trustworthy signals from the scientific record without drowning in irrelevant results. A free tier gives limited AI-powered searches each month, while paid plans unlock unlimited use, advanced filters and deeper synthesis.

**Pricing & Plans:** Freemium. A free tier offers a limited number of AI-powered searches per month; paid individual plans unlock unlimited searches and advanced research features, with discounted student pricing and team/enterprise options.

- **Evidence-grounded answers:** Ask a research question in plain language and get answers synthesized from peer-reviewed studies, with each claim linked to its source paper.
- **Consensus Meter:** A visual summary shows how the scientific literature leans on a yes/no question, indicating agreement, disagreement or mixed evidence.
- **Powerful filters:** Narrow results by study design, sample size, journal quality, publication year and more to prioritize high-quality evidence.
- **Topic synthesis and Deep Search:** Aggregate findings across many studies into structured summaries that map what is known and where the gaps are.
- **Research workspace:** Save papers, organize sources and build a persistent knowledge base for literature reviews and ongoing projects.

**Strengths:** Answers cite real peer-reviewed papers, so claims are verifiable; Consensus Meter makes it easy to gauge scientific agreement at a glance; Rich filters help separate high-quality evidence from weaker studies; Fast, clean interface designed around research workflows

**Limitations:** Free tier caps the number of AI-assisted searches per month; Coverage is strongest for STEM and health fields, lighter for some humanities topics; It guides you toward sources but is not a substitute for reading full papers

[Profile (Markdown)](https://openaitools.app/tool/consensus.md)

## Empedoc AI

EmpedocLabs, the company behind Empedoc AI, focuses on a preventive approach to neurology. Rather than reacting once a neurological event has already occurred, its AI aims to forecast events in advance so patients and clinicians can act earlier. The company frames this as shifting healthcare from reactive to preventive.

The flagship product is Phoebe, a migraine prediction engine. Phoebe combines Apple Watch biometrics with atmospheric pressure data and applies machine learning to forecast migraine attacks up to seven days ahead, giving sufferers advance warning rather than surprise onset. It is distributed as an iOS download.

A second, in-development product called Clara extends the same preventive philosophy to cognitive health. Clara is designed to detect early cognitive decline through passive behavioral and biometric analysis, providing continuous monitoring for neurodegenerative risk signals. EmpedocLabs is operated by EMPEDOC AI LLC, based in Niš, Serbia, and positions its road ahead at the intersection of wearables, atmospheric science, and machine learning for the nervous system.

**Pricing & Plans:** No public pricing is published on the site. As an early-stage medical AI company, EmpedocLabs is treated as contact-based: prospective users and partners reach out through its support and contact channels.

- **Migraine prediction (Phoebe):** Combines Apple Watch biometrics with atmospheric pressure data to forecast migraine attacks up to seven days in advance.
- **Cognitive decline detection (Clara):** Uses passive behavioral and biometric analysis to continuously monitor for early signs of neurodegenerative risk.
- **Wearable and atmospheric data fusion:** Fuses wearable readings with environmental signals such as barometric pressure to sharpen predictive accuracy.
- **Machine learning forecasting:** Machine learning models translate biometric and environmental streams into forward-looking, preventive insights.
- **Preventive-first design:** Aims to move neurological care from reactive treatment toward anticipatory, preventive management.

**Strengths:** Clear preventive focus that forecasts events instead of reacting to them; Phoebe pairs wearable biometrics with atmospheric data for up to 7-day migraine forecasts; Uses widely available Apple Watch data rather than custom hardware; Extends the approach to cognitive health with Clara

**Limitations:** Phoebe is iOS-only, so Android users are not yet supported; Clara, the cognitive-decline product, is still in development; No public pricing or self-serve plans listed; Preventive neurological prediction is a young field, so real-world accuracy should be evaluated over time

[Profile (Markdown)](https://openaitools.app/tool/empedoc-ai.md)

## Frequently Asked Questions

### How do Consensus and Empedoc AI compare in monthly traffic?

Consensus has 6,014,388 monthly visits, while Empedoc AI has 0. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Consensus has a month-over-month growth rate of -1.2%; Empedoc AI has 0%.

### How does pricing compare?

Consensus: Freemium. Freemium. A free tier offers a limited number of AI-powered searches per month; paid individual plans unlock unlimited searches and advanced research features, with discounted student pricing and team/enterprise options. Empedoc AI: Contact for Pricing. No public pricing is published on the site. As an early-stage medical AI company, EmpedocLabs is treated as contact-based: prospective users and partners reach out through its support and contact channels.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Perplexity](https://openaitools.app/tool/perplexity-ai) | 88,310,223 | -3.7% | Freemium | Covers general web sources alongside academic papers, but lacks specialized scientific synthesis metrics and consensus ratings. | [.md](https://openaitools.app/tool/perplexity-ai.md) |
| 2 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | Completely free access to a massive scholarly index, but offers less automated natural-language evidence synthesis than Consensus. | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 3 | [Kagi Search](https://openaitools.app/tool/kagi-search) | 4,647,605 | +3.2% | Free Trial, Paid | A paid, ad-free search engine that answers to its users | [.md](https://openaitools.app/tool/kagi-search.md) |
| 4 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | Provides deeper PDF reading and interactive literature analysis tools, but is less focused on quick evidence aggregation. | [.md](https://openaitools.app/tool/scispace.md) |
| 5 | [Ubie](https://openaitools.app/tool/ubie) | 2,941,054 | -23.2% | Free | Free AI symptom checker developed by doctors | [.md](https://openaitools.app/tool/ubie.md) |
| 6 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | Performs advanced systematic review data extraction and evidence synthesis, but has a more complex interface than Consensus. | [.md](https://openaitools.app/tool/elicit.md) |
| 7 | [Jenni](https://openaitools.app/tool/jenni) | 1,498,133 | +5.2% | Freemium | The AI workspace where researchers read, write, and cite with every claim traceable to its source | [.md](https://openaitools.app/tool/jenni.md) |
| 8 | [Doctronic AI Doctors + Human Doctors](https://openaitools.app/tool/doctronic-ai-doctors-human-doctors) | 1,131,516 | -24.8% | Freemium | AI health guidance with licensed doctors on demand | [.md](https://openaitools.app/tool/doctronic-ai-doctors-human-doctors.md) |
| 9 | [Rayyan](https://openaitools.app/tool/rayyan) | 1,116,437 | +7.9% | Freemium | AI-assisted systematic review software for screening, extraction, and evidence synthesis at scale | [.md](https://openaitools.app/tool/rayyan.md) |
| 10 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | Tracks how papers are cited with Smart Citations to gauge reliability, but features a less direct Q&A synthesis. | [.md](https://openaitools.app/tool/scite.md) |

---
Source: https://openaitools.app/compare/consensus-vs-empedoc-ai

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
